跳至主要内容
临床试验/JPRN-UMIN000013333
JPRN-UMIN000013333招募中1 期

PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer. - PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.

agoya City West Medical Center0 个研究点目标入组 35 人开始时间: 2014年3月4日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Hemorrhagic Diathesis, coagulopathy (2) Presence of cardiovascular invasion (3) Presence of any tumor with cavitation (4) Presence of significant interstitial lung disease or lung fibrosis (5) Uncontrolled intercurrent illness (eg. hypertension, diabetes mellitus, gastro- intestinal fistula, symptomatic congestive heart failure, unstable angina pectoris, serious cardiac arrhythmia) (6) Ongoing/active infection (7) Arterial thrombotic events or significant vascular disease (8) Uncontrolled gastric ulcer (9) Gastrointestinal perforation within the past 12 months (10) Prior malignancy (11) Uncontrolled pleural effusion or ascites (12) Clinically significant pericardial effusion (13) Hypersensitivity history for test drugs (14) Pregnancy or breast-feeding

研究者

发起方
agoya City West Medical Center

相似试验

PhaseI/II study of carboplatin plus nab-paclitaxel... | 临床试验